Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is revoking its regulations governing access to and promotion of nicotine-containing cigarettes and smokeless tobacco to children and adolescents. This action is being taken in response to the Supreme Court decision of March 21, 2000 in which the court held that Congress has not given FDA the authority to regulate tobacco products as customarily marketed. This action will result in the removal of the regulations.
This rule is effective March 31, 2000.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Anne Kirchner, Office of the Commissioner (HF-13), 5600 Fishers Lane, Rockville, MD 20857, 301-827-0585.End Further Info End Preamble Start Supplemental Information
In the Federal Register of August 11, 1995 (60 FR 41314), We (FDA) issued proposed regulations to restrict the sale and distribution of cigarettes and smokeless tobacco to children and adolescents. In addition, we issued a jurisdictional determination that cigarettes and smokeless tobacco products are combination products consisting of a drug (nicotine) and device components intended to deliver nicotine to the body. We issued final regulations based on this proposal in the Federal Register of August 28, 1996 (61 FR 44398).
On March 21, 2000, in Food and Drug Administration vs. Brown & Williamson Tobacco Corp., et al., the Supreme Court ruled that Congress has not granted FDA jurisdiction to regulate tobacco products as customarily marketed. In accordance with this ruling, we are hereby removing our regulations restricting the sale and distribution of cigarettes and smokeless tobacco to children and adolescents. Publication of this document constitutes final action under the Administrative Procedure Act (5 U.S.C. 553(b)(3)(B)). We are also addressing the additional steps necessitated by the courts ruling, such as termination of state contracts to help enforce the age and photo identification requirements of the regulations.Start List of Subjects
List of Subjects
End List of Subjects
Imports, Medical devices, Reporting and recordkeeping requirements.
Confidential business information, Imports, Medical devices, Reporting and recordkeeping requirements.
Medical devices, Reporting and recordkeeping requirements. Start Printed Page 17136
Advertising, Cigarettes, Labeling, Sale and distribution, Smokeless tobacco.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR parts 801, 803, 807, and 820 are amended and part 897 is removed as follows:Start Part
1. The authority citation for 21 CFR part 801 continues to read as follows:
2. Remove § 801.126.
PART 803—MEDICAL DEVICE REPORTING
3. The authority citation for 21 CFR part 803 continues to read as follows:End Part Start Part
PART 807—ESTABLISHMENT REGISTRATION AND DEVICE LISTING FOR MANUFACTURERS AND INITIAL DISTRIBUTORS OF DEVICES
5. The authority citation for 21 CFR part 807 continues to read as follows:
6. Amend § 807.65 by removing paragraph (j).End Part Start Part
PART 820—QUALITY SYSTEM REGULATION
7. The authority citation for 21 CFR part 820 continues to read as follows:
8. Amend § 820.1 by removing paragraphs (e) and (f).End Part Start Part
9. Remove part 897.Start Signature
Dated: March 28, 2000.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 00-7960 Filed 3-30-00; 8:45 am]
BILLING CODE 4160-01-F